RAPT Therapeutics Slips 9% After Pricing Public Offering

On:

Shares of RAPT Therapeutics, Inc. (RAPT) are down more than 9% Friday morning at $19.26.

The company today priced its public offering of 4,054,055 shares at $18.50 per share.

Gross proceeds of $75 million is estimated from the offering, which is expected to close on November 22.

RAPT has traded in the range of $9.85- $40.74 in the last 1 year.

Source: Read Full Article

Lates News:
  1. Debt Deal Euphoria Drains In China Despair
  2. Rate Hikes And Recession Fears Dampen Market Sentiment
  3. Bitcoin Enters Full Accumulation Season, With Shrimps and Whales Seizing Their Share Of The Pie
  4. Cryptos Muted As U.S. CPI Fails To Slide As Expected
  5. Bloomberg Strategist on $ETH vs $BTC: “Ethereum’s Upper Hand Could Be Enduring”